Inventor · disambiguated record
Pascal Druzgala
Also filed as: DRUZGALA PASCAL · DRUZGALA PASCAL J · DRUZGALA PASCAL JEAN
63 granted patents·19 pending applications·484 citations·filing 1993–2025
99Inventor score
Top patents by PatentIndex Score
82 records- 0197US11643409B2Material for the treatment of gastro-intestinal disordersRENEXXION LLC·Filed 2022·Granted May 9, 2023·3 cites·13 claims
- 0296US11827631B2Methods for the treatment of gastro-intestinal disordersRENEXXION LLC·Filed 2023·Granted Nov 28, 2023·2 cites·34 claims
- 0395US11759640B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2022·Granted Sep 19, 2023·5 cites·13 claims
- 0495US11498918B2Methods for the treatment of gastro-intestinal disordersRENEXXION LLC·Filed 2020·Granted Nov 15, 2022·4 cites·28 claims
- 0594US10570127B1Material and methods for the treatment of gastro-intestinal disordersRENEXXION LLC·Filed 2018·Granted Feb 25, 2020·5 cites·10 claims
- 0693US11975202B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2023·Granted May 7, 2024·2 cites·20 claims
- 0793US8138204B2Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disordersIRWIN IAN·Filed 2007·Granted Mar 20, 2012·20 cites·12 claims
- 0892US8524736B2Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disordersIRWIN IAN·Filed 2012·Granted Sep 3, 2013·26 cites·17 claims
- 0992US6552046B2Materials and methods for the treatment of gastroesophageal reflux diseaseARYX THERAPEUTICS·Filed 2001·Granted Apr 22, 2003·41 cites·33 claims
- 1091US12257228B2Cardioversion methods using budiodaroneXyra LLC·Filed 2023·Granted Mar 25, 2025·1 cites·24 claims
- 1191US12115373B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2023·Granted Oct 15, 2024·1 cites·20 claims
- 1291US7282509B2Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disordersARYX THERAPEUTICS·Filed 2005·Granted Oct 16, 2007·24 cites·58 claims
- 1390US12391684B2Pharmaceutical formulations and methods for the treatment of gastrointestinal disordersRENEXXION LLC·Filed 2024·Granted Aug 19, 2025·0 cites·18 claims
- 1490US6680387B2Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosisARYX THERAPEUTICS·Filed 2001·Granted Jan 20, 2004·21 cites·130 claims
- 1590US5364880ACompound for treatment of cardiac arrhythmia, synthesis, and methods of useADVANCED THERAPIES INC·Filed 1993·Granted Nov 15, 1994·34 cites·11 claims
- 1688US12098149B2Pharmaceutical formulations for the treatment of gastrointestinal disordersRENEXXION LLC·Filed 2023·Granted Sep 24, 2024·0 cites·7 claims
- 1788US6316487B1Compounds for treatment of cardiac arrhythmia synthesis, and methods of useARYX THERAPEUTICS·Filed 2000·Granted Nov 13, 2001·20 cites·34 claims
- 1887US6469064B2Materials and methods for the treatment of depressionARYX THERAPEUTICS·Filed 2001·Granted Oct 22, 2002·25 cites·10 claims
- 1987US5849788ACompound for treatment of cardiac arphythmia, synthesis, and methods of useARYX THERAPEUTICS·Filed 1995·Granted Dec 15, 1998·29 cites·16 claims
- 2086US6770655B25-HT3 receptor antagonists and methods of useARYX THERAPEUTICS·Filed 2003·Granted Aug 3, 2004·12 cites·11 claims
- 2186US6372783B1Enantiomeric compounds for treatment of cardiac arrhythmias and methods of useARYX THERAPEUTICS·Filed 2000·Granted Apr 16, 2002·21 cites·52 claims
- 2285US7285671B2Materials and methods for treating coagulation disordersARYX THERAPEUTICS·Filed 2006·Granted Oct 23, 2007·4 cites·12 claims
- 2385US7253208B2Materials and methods for treating coagulation disordersARYX THERAPEUTICS·Filed 2005·Granted Aug 7, 2007·6 cites·13 claims
- 2485US7105568B2Compounds for treatment of cardiac arrhythmia and methods of useARYX THERAPEUTICS INC·Filed 2005·Granted Sep 12, 2006·3 cites·15 claims
- 2585US7037933B2Compounds for treatment of cardiac arrhythmia, synthesis, and methods of useARYX THERAPEUTICS INC·Filed 2005·Granted May 2, 2006·4 cites·6 claims
- 2685US6362223B1Enantiomeric compounds for treatment of cardiac arrhythmias and methods of useARYX THERAPEUTICS·Filed 2000·Granted Mar 26, 2002·20 cites·52 claims
- 2784US6387914B2Ultrashort acting hypnotic barbituratesARYX THERAPEUTICS·Filed 2001·Granted May 14, 2002·10 cites·38 claims
- 2884US5440054ACompound for treatment of cardiac arrhythmia, synthesis, and methods of useADVANCED THERAPIES INC·Filed 1994·Granted Aug 8, 1995·21 cites·7 claims
- 2983US7125886B25-HT3 receptor antagonists and methods of useARYX THERAPEUTICS·Filed 2004·Granted Oct 24, 2006·9 cites·12 claims
- 3083US6683086B2Ultrashort acting hypnotic barbituratesARYX THERAPEUTICS·Filed 2002·Granted Jan 27, 2004·9 cites·26 claims
- 3182US7498449B2Antiarrhythmic precursor compounds, methods of synthesis and methods of useARYX THERAPEUTICS·Filed 2006·Granted Mar 3, 2009·3 cites·6 claims
- 3281US7666902B2Haloalkyl ester derivatives of coumarin for the treatment of coagulation disordersARYX THERAPEUTICS INC·Filed 2007·Granted Feb 23, 2010·2 cites·25 claims
- 3381US6864279B2Materials and methods for treating coagulation disordersARYX THERAPEUTICS·Filed 2002·Granted Mar 8, 2005·13 cites·15 claims
- 3481US6683195B2Enantiomeric compounds for treatment of cardiac arrhythmias and methods of useARYX THERAPEUTICS·Filed 2002·Granted Jan 27, 2004·8 cites·40 claims
- 3580US6130240ACompound for treatment of cardiac arrhythmia, synthesis, and methods of useARYX THERAPEUTICS INC·Filed 1998·Granted Oct 10, 2000·17 cites·16 claims
- 3679US11839768B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2023·Granted Dec 12, 2023·0 cites·38 claims
- 3779US7932405B2Halogenated ester derivatives of coumarins for the treatment of coagulation disordersARYX THERAPEUTICS INC·Filed 2008·Granted Apr 26, 2011·2 cites·5 claims
- 3878USRE42412EMaterials and methods for the treatment of gastroesophageal reflux diseaseARYX THERAPEUTICS INC·Filed 2007·Granted May 31, 2011·2 cites·33 claims
- 3975US7145020B2Materials and methods for treating coagulation disordersARYX THERAPEUTICS·Filed 2004·Granted Dec 5, 2006·4 cites·12 claims
- 4075US6710070B2Compounds for treatment of cardiac arrhythmia, synthesis, and methods of useARYX THERAPEUTICS·Filed 2002·Granted Mar 23, 2004·7 cites·16 claims
- 4174US7351842B2Compounds for treatment of cardiac arrhythmia and methods of useARYX THERAPEUTICS INC·Filed 2006·Granted Apr 1, 2008·1 cites·42 claims
- 4272US6951877B2Materials and methods for treating hypercholesterolemiaARYX THERAPEUTICS INC·Filed 2003·Granted Oct 4, 2005·3 cites·10 claims
- 4372US6869972B2Compounds for treatment of cardiac arrhythmia, synthesis, and methods of useARYX THERAPEUTICS·Filed 2004·Granted Mar 22, 2005·4 cites·16 claims
- 4471US6686377B2Ultrashort-acting opioids for transdermal applicationARYX THERAPEUTICS·Filed 2002·Granted Feb 3, 2004·3 cites·19 claims
- 4571US6608097B2Materials and methods for the treatment of hypertension and anginaARYX THERAPEUTICS·Filed 2002·Granted Aug 19, 2003·4 cites·14 claims
- 4668US7041673B2Ultrashort acting hypnotic barbituratesARYX THERAPEUTICS INC·Filed 2004·Granted May 9, 2006·2 cites·6 claims
- 4767USRE41289EUltrashort acting hypnotic barbituratesARYX THERAPEUTICS INC·Filed 2007·Granted Apr 27, 2010·0 cites·6 claims
- 4866US8691836B2D2 antagonists, methods of synthesis and methods of useLUEHR GARY W·Filed 2011·Granted Apr 8, 2014·2 cites·14 claims
- 4966US6809116B2Materials and methods for the treatment of depressionARYX THERAPEUTICS·Filed 2002·Granted Oct 26, 2004·2 cites·8 claims
- 5065US7001915B2Ultrashort-acting opioids for transdermal applicationsARYX THERAPEUTICS INC·Filed 2004·Granted Feb 21, 2006·1 cites·10 claims
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Pascal Druzgala files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →